Skip to main content
. 2016 Jan 21;114(3):281–289. doi: 10.1038/bjc.2015.453

Figure 2.

Figure 2

(A) Line graph showing the adjusted mean difference in Ki-67 proliferation index in paired pre- and postintervention endometrial tumours from metformin-treated and control patients. (B and C) Endometrial tumour stained for Ki-67 before (B) and after (C) treatment with metformin at × 20 magnification.